E-LIB Suche - Ergebnisse für: Argnani, Lisa

1

Economic evaluation of anti-CD19 CAR T-cell pathway for lar..:

Di Staso, Rossana ; Casadei, Beatrice ; Gentilini, Marianna...
Annals of Hematology. 103 (2024) 7 - p. 2499-2509 , 2024

Link: https://doi.org/10.1007/..

2

The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt..:

Broccoli, Alessandro ; Argnani, Lisa ; Gugliotta, Gabriele...
The Oncologist. 29 (2024) 6 - p. e789-e795 , 2024

Link: https://doi.org/10.1093/..

3

Successful Bridging to Allogeneic Transplantation With Vale..:

Bagnato, Gianmarco ; Stefoni, Vittorio ; Broccoli, Alessandro...
Mediterranean Journal of Hematology and Infectious Diseases. 16 (2024) 1 - p. e2024004 , 2024

Link: https://doi.org/10.4084/..

4

Pixantrone as bridging therapy to allogeneic transplantatio..:

Lolli, Ginevra ; Argnani, Lisa ; Gini, Guido...
Hematological Oncology. 41 (2023) 5 - p. 947-950 , 2023

Link: https://doi.org/10.1002/..

5

Prolonged Complete Response with Lenalidomide in a Relapsed..:

Zoli, Sabrina ; Pellegrini, Cinzia ; Casadei, Beatrice...
Chemotherapy. 69 (2023) 1 - p. 23-26 , 2023

Link: https://doi.org/10.1159/..

6

Single-agent rituximab is an effective salvage therapy in p..:

Broccoli, Alessandro ; Argnani, Lisa ; Nanni, Laura...
Blood Advances. 7 (2023) 21 - p. 6762-6766 , 2023

Link: https://doi.org/10.1182/..

7

Diffuse large B cell lymphoma characteristics and outcomes ..:

Giladi, Odil ; Bagnato, Gianmarco ; Gentilini, Marianna...
Annals of Hematology. 103 (2023) 3 - p. 803-811 , 2023

Link: https://doi.org/10.1007/..

8

P1070: DECISIONAL ROLE OF INTERIM PET IN RELAPSED/REFRACTOR..:

Rusconi, Chiara ; Ricci, Francesca ; Daffini, Rosa...
HemaSphere. 7 (2023) S3 - p. e95482eb , 2023

Link: https://doi.org/10.1097/..

9

Brentuximab vedotin in the treatment of relapsed/refractory..:

Stefoni, Vittorio ; Pellegrini, Cinzia ; Argnani, Lisa...
Hematological Oncology. 40 (2022) 2 - p. 307-309 , 2022

Link: https://doi.org/10.1002/..

10

BEGEV salvage regimen in relapsed/refractory classical Hodg..:

Stefoni, Vittorio ; Argnani, Lisa ; Carella, Matteo...
Journal of Cancer Research and Clinical Oncology. 149 (2022) 3 - p. 1043-1047 , 2022

Link: https://doi.org/10.1007/..

11

Real-world Outcomes of Relapsed/Refractory Diffuse Large B-..:

Argnani, Lisa ; Broccoli, Alessandro ; Pellegrini, Cinzia...
HemaSphere. 6 (2022) 12 - p. e798 , 2022

Link: https://doi.org/10.1097/..

12

An international analysis evaluating frontline bendamustine..:

Alderuccio, Juan Pablo ; Arcaini, Luca ; Watkins, Marcus P....
Blood Advances. 6 (2022) 7 - p. 2035-2044 , 2022

Link: https://doi.org/10.1182/..

13

Prolonged responses to brentuximab vedotin as last therapy ..:

Broccoli, Alessandro ; Argnani, Lisa ; Coppola, Paolo Elia...
Tumori Journal. 109 (2022) 2 - p. 249-252 , 2022

Link: https://doi.org/10.1177/..

14

Treatment with Idelalisib in Patients with Relapsed or Refr..:

Casadei, Beatrice ; Argnani, Lisa ; Broccoli, Alessandro...
Cancers. 14 (2022) 3 - p. 654 , 2022

Link: https://doi.org/10.3390/..

15

Cost‐Effectiveness of the Early Arthritis Clinic Organizati..:

Zanetti, Anna ; Sakellariou, Garifallia ; Zambon, Antonella...
Arthritis Care & Research. 75 (2022) 5 - p. 1046-1051 , 2022

Link: https://doi.org/10.1002/..